LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN

Background: Langerhans cell histiocytosis (LCH) is a rare proliferative disorder of histiocytes encompasses a wide clinical spectrum, ranging from a benign localized disease to acute generalized disease with fatal outcome. Objectives: to retrospectively evaluate clinical characteristics at diagnosis...

Full description

Bibliographic Details
Main Authors: MAZIN F. AL-JADIRY, SALMA A. AL-HADAD, KHALID Q. ABD
Format: Article
Language:English
Published: College of Medicine University of Baghdad 2008-10-01
Series:مجلة كلية الطب
Subjects:
Online Access:http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1243
_version_ 1827392652991004672
author MAZIN F. AL-JADIRY
SALMA A. AL-HADAD
KHALID Q. ABD
author_facet MAZIN F. AL-JADIRY
SALMA A. AL-HADAD
KHALID Q. ABD
author_sort MAZIN F. AL-JADIRY
collection DOAJ
description Background: Langerhans cell histiocytosis (LCH) is a rare proliferative disorder of histiocytes encompasses a wide clinical spectrum, ranging from a benign localized disease to acute generalized disease with fatal outcome. Objectives: to retrospectively evaluate clinical characteristics at diagnosis and outcome of patients with Langerhans cell histiocytosis. Patients and methods: A retrospective analysis of data on 21 children with Langerhans cell histiocytosis followed at Oncology unit, Children Welfare Teaching Hospital, Medical City, Baghdad, between 1999 and 2006. Results : The age at time of diagnosis of LCH ranged from 3 months to 9 years, with a median of 22 months, and male to female ratio was 1:1.1. The duration of the onset of the disease before diagnosis ranged from 1month to1 year. Bone lesions, skin lesions and LAP were the common presenting features. Skull was the major site of lytic lesions 10(47.6%) patients. Tissue biopsy and/or aspiration were the main diagnostic procedures. Twenty patients treated by different combinations of chemotherapy. Ten patients survived (50%), and the mean time of follow up was 28 months. Conclusion : The study showed a relatively high incidence of advanced (III and IV) stages of disease 12 patients (57.1 %) with subsequent poor outcome and survival. Recommendation : Long term follow-up by a multidisciplinary care team is required
first_indexed 2024-03-08T17:36:20Z
format Article
id doaj.art-d9648c30b1af497083c5869efda75e8a
institution Directory Open Access Journal
issn 0041-9419
2410-8057
language English
last_indexed 2024-03-08T17:36:20Z
publishDate 2008-10-01
publisher College of Medicine University of Baghdad
record_format Article
series مجلة كلية الطب
spelling doaj.art-d9648c30b1af497083c5869efda75e8a2024-01-02T12:43:37ZengCollege of Medicine University of Baghdadمجلة كلية الطب0041-94192410-80572008-10-0150310.32007/1243%g296-302LANGERHANS CELL HISTIOCYTOSIS IN CHILDRENMAZIN F. AL-JADIRY0SALMA A. AL-HADAD1KHALID Q. ABD2Oncology unit, Department of paediatrics, Baghdad Medical College, Children Welfare Teaching Hospital, Medical City.Oncology unit, Department of paediatrics, Baghdad Medical College, Children Welfare Teaching Hospital, Medical City.Children Welfare Teaching HospitalBackground: Langerhans cell histiocytosis (LCH) is a rare proliferative disorder of histiocytes encompasses a wide clinical spectrum, ranging from a benign localized disease to acute generalized disease with fatal outcome. Objectives: to retrospectively evaluate clinical characteristics at diagnosis and outcome of patients with Langerhans cell histiocytosis. Patients and methods: A retrospective analysis of data on 21 children with Langerhans cell histiocytosis followed at Oncology unit, Children Welfare Teaching Hospital, Medical City, Baghdad, between 1999 and 2006. Results : The age at time of diagnosis of LCH ranged from 3 months to 9 years, with a median of 22 months, and male to female ratio was 1:1.1. The duration of the onset of the disease before diagnosis ranged from 1month to1 year. Bone lesions, skin lesions and LAP were the common presenting features. Skull was the major site of lytic lesions 10(47.6%) patients. Tissue biopsy and/or aspiration were the main diagnostic procedures. Twenty patients treated by different combinations of chemotherapy. Ten patients survived (50%), and the mean time of follow up was 28 months. Conclusion : The study showed a relatively high incidence of advanced (III and IV) stages of disease 12 patients (57.1 %) with subsequent poor outcome and survival. Recommendation : Long term follow-up by a multidisciplinary care team is requiredhttp://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1243Langerhans Cell Histiocytosis, children
spellingShingle MAZIN F. AL-JADIRY
SALMA A. AL-HADAD
KHALID Q. ABD
LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
مجلة كلية الطب
Langerhans Cell Histiocytosis, children
title LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
title_full LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
title_fullStr LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
title_full_unstemmed LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
title_short LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
title_sort langerhans cell histiocytosis in children
topic Langerhans Cell Histiocytosis, children
url http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1243
work_keys_str_mv AT mazinfaljadiry langerhanscellhistiocytosisinchildren
AT salmaaalhadad langerhanscellhistiocytosisinchildren
AT khalidqabd langerhanscellhistiocytosisinchildren